PI
AUPH icon

PEAK6 Investments’s Aurinia Pharmaceuticals AUPH Stock Holding History

PEAK6 Investments’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-75,400
Closed -$678K – 4018
2023
Q4 		$678K Hold
75,400
– – ﹤0.01% 2394
2023
Q3 		$586K Hold
75,400
– – ﹤0.01% 2256
2023
Q2 		$730K Hold
75,400
– – ﹤0.01% 1924
2023
Q1 		$826K Hold
75,400
– – ﹤0.01% 1989
2022
Q4 		$326K Hold
75,400
– – ﹤0.01% 2890
2022
Q3 		$567K Sell
75,400
-75,400
-50% -$653K ﹤0.01% 2749
2022
Q2 		$1.49M Buy
150,800
+75,400
+100% +$843K ﹤0.01% 2650
2022
Q1 		$933K Hold
75,400
– – ﹤0.01% 2564
2021
Q4 		$1.72M Buy
+75,400
New +$1.79M ﹤0.01% 2047

Other funds holding AUPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PEAK6 Investments's AUPH Position: Q1 2024 in Review

PEAK6 Investments sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2024, closing a stake of 72,239 shares — an estimated $649K sold.

PEAK6 Investments first reported a position in AUPH in Q4 2021 and held it in 9 quarters. The position peaked at $851K in Q2 2022. 179 funds tracked by Wall St. Rank hold AUPH as of Q1 2024.

  • PEAK6 Investments reported no remaining Aurinia Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • PEAK6 Investments sold 72,239 Aurinia Pharmaceuticals shares in Q1 2024, an estimated $649K.
  • PEAK6 Investments first reported a position in Aurinia Pharmaceuticals in Q4 2021 and held it in 9 quarters.
  • PEAK6 Investments's Aurinia Pharmaceuticals position peaked at $851K in Q2 2022.
  • 179 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2024.

Based on PEAK6 Investments's 13F filing for Q1 2024, filed 14 May 2024.